"Ready, set, go": checkpoint regulation by Cdk1 inhibitory phosphorylation

J O Ayeni1, S D Campbell

  • 1a Department of Biological Sciences ; University of Alberta ; Edmonton , AB , Canada.

Fly
|December 9, 2014
PubMed

Insights

Cell cycle checkpoints use inhibitory phosphorylation of Cdk1 to prevent mitosis. This study reveals complex checkpoint states beyond a simple on/off switch, crucial for DNA repair and cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Cell cycle checkpoints are essential for preventing mitosis until DNA replication and repair are complete.
  • Cdk1 (Cyclin-dependent kinase 1) is a key regulator of mitosis onset, controlled by inhibitory phosphorylation.
  • Metazoans possess two distinct Cdk1 inhibitory kinases: Wee1 and Myt1.

Purpose of the Study:

  • To investigate how the distinct biochemical properties of Wee1 and Myt1 affect Cdk1 phosphorylation and cell cycle control.
  • To analyze the roles of specific Cdk1 phosphorylation sites (Y15 and T14) in G2/M checkpoint function.

Main Methods:

  • Utilized transgenic Cdk1 phospho-acceptor mutants.
  • Analyzed the functional consequences of specific Cdk1 phosphorylation events in imaginal wing discs.

Main Results:

  • Phosphorylation of Cdk1 on Y15 is necessary and sufficient for G2/M checkpoint arrest.
  • Phosphorylation on T14 contributes to chromosome stability through a distinct mechanism.
  • A complex interplay exists between inhibitory Y15 phosphorylation and activating T161 phosphorylation.

Conclusions:

  • The G2/M checkpoint is not a binary switch but involves at least three distinct states: 'Ready', 'Set', and 'Go'.
  • These findings reveal unexpected complexities in Cdk1 inhibitory phosphorylation, impacting cell cycle regulation and genomic stability.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K